|
Jul 14, 2021
Coya Therapeutics to Participate at the LifeSci Partners Summer Symposium
|
|
|
Jul 07, 2021
Coya Therapeutics Receives Orphan Drug Designation from the FDA for ALS001, an Autologous Treg Cell Therapy, for the Treatment of ALS
|
|
|
Jun 02, 2021
Coya Therapeutics to Host Key Opinion Leader Webinar on ALS001 for the Treatment of Amyotrophic Lateral Sclerosis
|
|
|
Jun 01, 2021
Ann Lee, Ph.D., SVP at Bristol Myers Squibb, Joins Coya Therapeutics™ Board of Directors
|
|
|
May 25, 2021
Coya Therapeutics™ Announces the Appointment of Anabella Villalobos, Ph.D. to its Board of Directors
|
|
|
Apr 14, 2021
Coya Therapeutics™ Announces the Appointment of Hideki Garren, M.D., Ph.D., and Dov Goldstein, M.D., to Its Board of Directors
|
|
|
Feb 23, 2021
Coya Therapeutics™ Announces Formation of Scientific Advisory Board
|
|